1 documents found
Information × Registration Number 0211U009107, 0108U000117 , R & D reports Title Experimental ground of expediency of use of the dimeodipin Ca antagonist fluor-containing and the agonist of PF-5 potassium canals ATP-dependent in miocardial ischemia. popup.stage_title Head Mochort N.A., Registration Date 29-06-2011 Organization State Establishment "Institute of Pharmacology and Toxicology National Academy of Medical Science of Ukraine" popup.description2 Specific pharmacologial activity of the dimeodipin 1,4-dihydropyridine derivative as a potential Ca antagonist to influence on coronary blood flow and on inotropic cardiac function was studied as well as ability for influence on cytolitic and power processes in the miocardium at miocardial ischemia produced by different etiologic factors. There was studied the agonist of PF-5 potassium canals ATP-depedent ability for influence on activity of the blood serum transaminase and of the miocardium in the adrenal cardiomyopathia calcium chloride arrhythmia, and dosorubicin cardiomyodistrophia. Product Description popup.authors Киричок Лора Михайлівна Мисливець Світлана Онисимівна Притула Тетяна Павлівна Пупишева Олена Володимирівна Сачок Віолета Вікторівна Серединська Наталія Миколаївна popup.nrat_date 2020-04-02 Close
R & D report
Experimental ground of expediency of use of the dimeodipin Ca antagonist fluor-containing and the agonist of PF-5 potassium canals ATP-dependent in miocardial ischemia.
Head: Mochort N.A.. Experimental ground of expediency of use of the dimeodipin Ca antagonist fluor-containing and the agonist of PF-5 potassium canals ATP-dependent in miocardial ischemia.. (popup.stage: ). State Establishment "Institute of Pharmacology and Toxicology National Academy of Medical Science of Ukraine". № 0211U009107
1 documents found

Updated: 2026-03-23


Роздрукувати цю сторінку